Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page history now shows a new revision entry: Revision: v3.3.2. This is a minor metadata update related to the revision history.
    Difference
    0.1%
    Check dated 2025-12-01T17:37:43.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision v3.3.1 was added to the Study Record Versions, and Revision v3.2.0 was deleted.
    Difference
    0.1%
    Check dated 2025-11-24T14:48:24.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Deleted a general operating-status notice about government funding; it does not alter the study record or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:56:07.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Version 2 (2019-06-11) updates the study record with a Recruitment Status change. This reflects a new enrollment status for the EARLY trial (NCT03750760).
    Difference
    0.1%
    Check dated 2025-11-03T01:20:21.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    13%
    Check dated 2025-10-05T10:29:22.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T03:23:09.000Z thumbnail image

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.